PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

FDA issues warning letter to Zhejiang Huahai Pharmaceutical involved in valsartan recall

The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the...
Continue Reading →
News

New Zealand moves towards legalising medical cannabis

New Zealand’s parliament has passed an amendment to the Misuse of Drugs Act 1975 that will allow terminally ill patients to possess and use cannabis. Previously...
Continue Reading →
News

Scientists develop revolutionary tech to improve prostate cancer detection

A ‘revolutionary’ new medical software able to pinpoint the area from which surgeons should take a biopsy to detect prostate cancer has been developed by NIHR s...
Continue Reading →
News

Brexit 'no deal' could mean 6 months of disruption for pharma

In an update from the U.K. government, Matt Hancock, the Secretary of State for Health and Social Care, has raised the specter of border delays and "no deal,"&...
Continue Reading →
News

Global atopic dermatitis market set to reach $18.3bn by 2027, says GlobalData

The atopic dermatitis market is expected to grow from $6.4bn in 2017 to $18.3bn in 2027 across the seven major markets (7MM*) at a compound annual growth rate (CAGR)...
Continue Reading →
News

Avacta and LG Chem Life Sciences agree multi-target Affimer therapeutics development alliance

Cambridge, UK and Seoul, South Korea, 10 December 2018: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and LG Chem L...
Continue Reading →
News

Trade Minister visit spotlights Second Sector Deal boost to UK life sciences and international potential

Global health technology and human data sciences company, IQVIA, welcomes Baroness Fairhead to UK HQ after £44m Sector Deal announcements The UK’s Minister fo...
Continue Reading →
News

PCI Continues to Invest According to Market Demand as Specialist 2-8°C Cold Chain Capabilities Become Operational at Hay-on-Wye, UK Site

Hay-on-Wye Center of Excellence increases capacity for onsite 2-8°C Cold Chain storage. Philadelphia, USA – December 10, 2018 PCI Pharma Services (PCI),...
Continue Reading →
News

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

Philadelphia, USA – December 3, 2018 PCI Pharma Services (PCI), full-service provider of specialist outsourced drug manufacturing, clinical trial services, and ...
Continue Reading →
News

PCI Pharma Services Celebrates Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

Aspire Blaenau Gwent Shared Apprenticeship Programme Award Winners 2018: PCI’s Macauley Webber (back row, second left) Philadelphia, PA – December 3, 2018 PC...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026